PRL-3 upregulation in colon cancer cells and primary fibroblasts induces telomere structural abnormalities, telomere deprotection, DNA damage response, chromosomal instability, and senescence, contributing to tumor progression [121]. The gene discussed is PTP4A3; the disease is neoplasm.